Moreover, our demonstration of increased GAB1Y627 phosphorylation in BCR-stimulated CLL cells from ibrutinib-treated patients suggests that more proximal effectors become involved when BTK activity is lost. Here, BTK is linked to B-cell chronic lymphocytic leukemia.